{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:00:18Z","timestamp":1781107218210,"version":"3.54.1"},"reference-count":29,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1297\/cpe.28.113","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T18:03:58Z","timestamp":1571421838000},"page":"113-125","source":"Crossref","is-referenced-by-count":2,"title":["Rapid increase in the incidence of end-stage renal disease in patients with          type 1 diabetes having HbA1c 10% or higher for 15 years"],"prefix":"10.1297","volume":"28","author":[{"given":"Toshika","family":"Otani","sequence":"first","affiliation":[{"name":"Diabetes Center, Tokyo Women\u2019s Medical University              School of Medicine, Tokyo, Japan"},{"name":"Omiya Kyoritsu Hospital, Saitama,            Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Jiyugaoka Medical Clinic, Internal Medicine, Obihiro,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Hanai","sequence":"additional","affiliation":[{"name":"Diabetes Center, Tokyo Women\u2019s Medical University              School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnosuke","family":"Miura","sequence":"additional","affiliation":[{"name":"Diabetes Center, Tokyo Women\u2019s Medical University              School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Uchigata","sequence":"additional","affiliation":[{"name":"Diabetes Center, Tokyo Women\u2019s Medical University              School of Medicine, Tokyo, Japan"},{"name":"Tokyo Women\u2019s Medical University Medical Center East,              Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Babazono","sequence":"additional","affiliation":[{"name":"Diabetes Center, Tokyo Women\u2019s Medical University              School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rosolowsky,                ET,              Skupien, J,                Smiles, AM,                Niewczas,            M, Roshan,                B, Stanton,                R, et al.            Risk for ESRD in type 1 diabetes remains high despite            renoprotection. J Am Soc Nephrol          2011;22: 545\u201353.","DOI":"10.1681\/ASN.2010040354"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Forsblom,                C,                Harjutsalo,              V, Thorn,                LM, Wad\u00e9n,                J, Tolonen,                N,                Saraheimo,              M, et al.            FinnDiane Study Group. Competing-risk analysis            of ESRD and death among patients with type 1 diabetes and            macroalbuminuria. J Am Soc Nephrol          2011;22: 537\u201344.","DOI":"10.1681\/ASN.2010020194"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Helve,              J, Sund,                R, Arffman,                M,                Harjutsalo,              V, Groop,                PH,                Gr\u00f6nhagen-Riska,              C, et al.            Incidence of end-stage renal disease in patients with type 1            diabetes. Diabetes Care          2018;41: 434\u20139.","DOI":"10.2337\/dc17-2364"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Otani,              T, Yokoyama,                H, Ohashi,                Y,              Uchigata,            Y. Improved            incidence of end-stage renal disease of type 1 diabetes in Japan, from a hospital-based            survey. BMJ Open Diabetes Res Care          2016;4: e000177.","DOI":"10.1136\/bmjdrc-2015-000177"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Contal,              C,              O\u2019Quingley,            J. An application            of changepoint methods in studying the effect of age on survival in breast            cancer. Comput Stat Data Anal          1999;30: 253\u201370.","DOI":"10.1016\/S0167-9473(98)00096-6"},{"key":"6","unstructured":"6. Seino,              Y, Nanjo,                K, Tajima,                N,              Kadowaki, T,                Kashiwagi,              A, Araki,                E, et al.            Report of the Committee on the classification and diagnostic criteria of            diabetes mellitus (the version for international standardization). The committee of            Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus.            J Jpn Diabetes Soc          2012;55:          485\u2013504."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Uchigata,                Y, Asao,                K,                Matsushima,              M, Sato,                A,              Yokoyama, H,                Otani, T,              et al. Impact on mortality and incidence of            end-stage renal disease of education and treatment at a diabetes center among patients            with type 1 diabetes: comparison of two subgroups in the Japanese DERI            cohort. J Diabetes Complications          2004;18: 155\u20139.","DOI":"10.1016\/j.jdiacomp.2003.10.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kashiwagi,                A, Kasuga,                M, Araki,                E, Oka,                Y,              Hanafusa, T,                Ito, H,              et al. International clinical harmonization            of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin            Standardization Program values. Committee on the Standardization of Diabetes            Mellitus-Related Laboratory Testing of Japan Diabetes Society (JDS).            Diabetol Int          2012;3: 8\u201310.","DOI":"10.1007\/s13340-012-0069-8"},{"key":"9","unstructured":"9. Kohno,              H. In: Ohzeki T, Kondo N,          editors. Shoni-shishunki no hatsuiku. Tokyo: Igakushoin; 2008. p. 13-5 (in          Japanese)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Klein,              R, Klein,                BE, Moss,                SE,                Cruickshanks,              KJ, Brazy,                PC. The            10-year incidence of renal insufficiency in people with type 1 diabetes.            Diabetes Care          1999;22: 743\u201351.","DOI":"10.2337\/diacare.22.5.743"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rossing,              P, Hougaard,                P, Parving,                HH. Risk            factors for development of incipient and overt diabetic nephropathy in type 1 diabetic            patients: a 10-year prospective observational study. Diabetes            Care          2002;25: 859\u201364.","DOI":"10.2337\/diacare.25.5.859"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nishimura,                R, Dorman,                JS,              Bosnyak, Z,                Tajima, N,                Becker, DJ,                Orchard,            TJ, Diabetes            Epidemiology Research International Mortality StudyAllegheny            County Registry. Incidence of ESRD and survival after renal            replacement therapy in patients with type 1 diabetes: a report from the Allegheny County            Registry. Am J Kidney Dis          2003;42: 117\u201324.","DOI":"10.1016\/S0272-6386(03)00414-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nathan,              DM, Zinman,                B, Cleary,                PA,                Backlund,              JY, Genuth,                S, Miller,                R, et al.            Diabetes Control and Complications Trial\/Epidemiology of Diabetes            Interventions and Complications (DCCT\/EDIC) Research Group.            Modern-day clinical course of type 1 diabetes mellitus after 30 years\u2019            duration: the diabetes control and complications trial\/epidemiology of diabetes            interventions and complications and Pittsburgh epidemiology of diabetes complications            experience (1983-2005). Arch Intern Med          2009;169: 1307\u201316.","DOI":"10.1001\/archinternmed.2009.193"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Skupien,              J, Warram,                JH, Smiles,                AM,                Niewczas,              MA, Gohda,                T,                Pezzolesi,              MG, et al.            The early decline in renal function in patients with type 1 diabetes and            proteinuria predicts the risk of end-stage renal disease. Kidney            Int          2012;82: 589\u201397.","DOI":"10.1038\/ki.2012.189"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Skupien,              J, Warram,                JH, Smiles,                A, Galecki,                A, Stanton,                RC,                Krolewski,              AS. Improved            glycemic control and risk of ESRD in patients with type 1 diabetes and            proteinuria. J Am Soc Nephrol          2014;25: 2916\u201325.","DOI":"10.1681\/ASN.2013091002"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Lecaire,                TJ, Klein,                BE, Howard,                KP, Lee,                KE, Klein,                R. Risk for            end-stage renal disease over 25 years in the population-based WESDR            cohort. Diabetes Care          2014;37: 381\u20138.","DOI":"10.2337\/dc13-1287"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Finne,              P, Reunanen,                A, Stenman,                S, Groop,                PH,                Gr\u00f6nhagen-Riska,              C. Incidence of            end-stage renal disease in patients with type 1 diabetes.            JAMA          2005;294: 1782\u20137.","DOI":"10.1001\/jama.294.14.1782"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gagnum,              V, Saeed,                M, Stene,                LC,                Leivestad,              T, Joner,                G,                Skrivarhaug,              T. Low            incidence of end-stage renal disease in childhood-onset type 1 diabetes followed for up            to 42 years. Diabetes Care          2018;41: 420\u20135.","DOI":"10.2337\/dc17-0906"},{"key":"19","unstructured":"19. Uesugi,              N, Ueda,                Y, Ubara,                Y,              Kitamura, H,                Sato, H,                Shimizu, M,              et al. Manual for pathological diagnosis of diabetic          nephropathy and hypertensive nephrosclerosis. In: Wada T, Yuzawa Y, supervisors. Tokyo:          Tokyo Igakusha; 2015.p.19-60 (in Japanese)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. UK Prospective Diabetes Study            Group. Tight blood pressure control and risk of            macrovascular and microvascular complications in type 2 diabetes: UKPDS            38. BMJ          1998;317: 703\u201313.","DOI":"10.1136\/bmj.317.7160.703"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. de                Galan, BE,                Perkovic,            V, Ninomiya,                T, Pillai,                A, Patel,                A, Cass,                A, et al.            ADVANCE Collaborative Group. Lowering blood            pressure reduces renal events in type 2 diabetes. J Am Soc            Nephrol          2009;20: 883\u201392.","DOI":"10.1681\/ASN.2008070667"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Schrier,                RW,              Estacio, RO,                Esler, A,                Mehler,            P. Effects of            aggressive blood pressure control in normotensive type 2 diabetic patients on            albuminuria, retinopathy and strokes. Kidney Int          2002;61: 1086\u201397.","DOI":"10.1046\/j.1523-1755.2002.00213.x"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. The Microalbuminuria Captopril Study            Group. Captopril reduces the risk of nephropathy in IDDM            patients with microalbuminuria. Diabetologia          1996;39: 587\u201393.","DOI":"10.1007\/s001250050482"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Laffel,              LM, McGill,                JB, Gans,                DJ, North            American Microalbuminuria Study Group. The beneficial            effect of angiotensin-converting enzyme inhibition with captopril on diabetic            nephropathy in normotensive IDDM patients with microalbuminuria.            Am J Med          1995;99: 497\u2013504.","DOI":"10.1016\/S0002-9343(99)80226-5"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. The EUCLID Study          Group. Randomised placebo-controlled trial of lisinopril in            normotensive patients with insulin-dependent diabetes and normoalbuminuria or            microalbuminuria. Lancet          1997;349: 1787\u201392.","DOI":"10.1016\/S0140-6736(96)10244-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Colhoun,                HM,                Betteridge,              DJ,                Durrington,              PN, Hitman,                GA, Neil,                HA,                Livingstone,              SJ, et al.            CARDS Investigators. Effects of atorvastatin            on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis            from the Collaborative Atorvastatin Diabetes Study (CARDS). Am J            Kidney Dis          2009;54: 810\u20139.","DOI":"10.1053\/j.ajkd.2009.03.022"},{"key":"27","unstructured":"27. Guidelines for the management of diabetes          mellitus based on scientific basis in 2013, Japan Diabetes Society (ed.). Nankodo Co.,          Ltd., Tokyo, 2013. pp97\u2013107 (in Japanese)."},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Kuriyama,                S,              Tomonari, H,                Yoshida, H,                Hashimoto,              T, Kawaguchi,                Y, Sakai,                O. Reversal            of anemia by erythropoietin therapy retards the progression of chronic renal failure,            especially in nondiabetic patients. Nephron          1997;77: 176\u201385.","DOI":"10.1159\/000190270"},{"key":"29","unstructured":"29. Babazono,                T, Yoshida,                N, Nyumura,                I, Toya,                K, Hayashi,                T, Bouchi,                R, et al.            Influence of albuminuria and glomerular filtration rate on HbA1c in            diabetics. The 53rd Annual Meeting of the Japan Diabetes Society.            J Jpn Diabetes Soc          2010;53(Suppl 1):            S261."}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/28\/4\/28_2019-0009\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T23:37:44Z","timestamp":1571441864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/28\/4\/28_2019-0009\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.28.113","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}